Quote of FIDSON HEALTHCARE PLC (FIDSON)
 
LClose 3.50 Price 3.50
Change 0.00 (0.00%) Low 3.50
High 3.50 EPS 0.24
PE 11.33 Shares Outs. 2,086,360,250
52WkHigh 4.05 52WkLow 2.21
50d Mov Avg 3.65 200d Mov Avg 3.00
AvgDlyVol 418,517.44 3MthChg 0.43 (14.01%)
6MthChg 1.29 (58.37%) 12MthChg -1.00 (-22.22%)
Div. Yield 4.2857 Risk Factor 0.001011394
Sector Pharmaceuticals
Company Profile

Fidson Healthcare Plc engages in the manufacture and distribution of pharmaceutical products in Nigeria. The company offers pharmaceutical products in various therapeutic areas, such as anti-infective, anti-arthritis, endocrinology, gastro-intestine, anti-retroviral, anti-malaria, cardiovascular, anti-depressant, pain relievers, haematinics, cough expectorants, and consumer goods. Its principal products include Biosulin-N, which is an anti-diabetic insulin; Gascol for heartburn, indigestion, dyspepsia, flatulence, and other acid-related disorders; Asomex 2.5 for acute uncomplicated UTI, complicated UTI, enteric fever, bone and joint infections, and adnexitis and prostatitis2; and Cutenox for the prevention of thrombosis in hospitalized medical and surgical patients. The company also offers Flutex for patients with depressive disorder, obsessive compulsive disorders, and bulima nervosa; Ciprotab 500, a second generation fluoroquinolone antibiotic for the treatment of various infections; ZETGEL to relieve pain in osteoarthrtis; and Astyfer Blood Builder for use in pregnancy, lactation, anaemia, haemorrhoids, anal fissures, chronic gastric ulcers, and iron deficiency; and Tuxil-C cough expectorant. In addition, it provides Formula 103, a razor less hair removal for men and women; baby diapers under Cuddles name; and tissue products under Fluffy brand. The company was incorporated in 1995 and is headquartered in Lagos, Nigeria. Website: www.fidson.com Founded in: 1995


Income statement

Statement of Comprehensive Income as at
31-Mar-2018

Name Amount
Revenue 16,229,903.00
Profit before taxation 160,867.00
Taxation 258,314.00
Profit after tax -97,447.00
Transfer to revenue reserve -322,447.00
Profit attributable to:
Owners of the company -97,447.00
Non-controlling interest
Earnings per 50k share (k) -6.00
Net assets per 50k share (k) 477.00